Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2025	Sep. 28, 2024	Sep. 27, 2025	Sep. 28, 2024	Dec. 28, 2024	Dec. 30, 2023
Summary of Significant Accounting Policies [Line Items]
Financing Receivable, Sale	$ 120,400	$ 125,100	$ 375,100	$ 420,700
Financing Receivable, Significant Sales, Transaction Fees	1,400	1,800	4,300	6,300
Basic:
Net income	$ 19,363	$ 16,949	$ 5,864	$ 176,972
Shares (in shares)	158,356,000	159,200,000	158,512,000	159,609,000
Per Share (in usd per share)	$ 0.12	$ 0.11	$ 0.04	$ 1.11
Effect of dilutive securities: [Abstract]
Add: Option shares in the money and dilutive effect of non-vested stock (in shares)	2,638,000	2,875,000	2,633,000	2,937,000
Less: Pro forma treasury shares (in shares)	(1,047,000)	(1,084,000)	(1,078,000)	(1,012,000)
Diluted:
Net Income	$ 19,363	$ 16,949	$ 5,864	$ 176,972
Shares (in shares)	159,947,000	160,991,000	160,067,000	161,534,000
Per Share (in usd per share)	$ 0.12	$ 0.11	$ 0.04	$ 1.10
Antidilutive Securities [Abstract]
Cash and cash equivalents	$ 91,494		$ 91,494		$ 75,973
Restricted cash	15,559		15,559		37,579
Restricted cash included in other long-term assets	97,136		97,136		103,755
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 204,189	$ 260,940	$ 204,189	$ 260,940	$ 217,307	$ 264,450
Stock Options
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	0	0	0
Non Vested Stock
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	364,000	578,342	474,963	585,511